These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 20089383)

  • 1. Predictors of acute kidney injury associated with intravenous colistin treatment.
    Kwon JA; Lee JE; Huh W; Peck KR; Kim YG; Kim DJ; Oh HY
    Int J Antimicrob Agents; 2010 May; 35(5):473-7. PubMed ID: 20089383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attributable Risk and Time Course of Colistin-Associated Acute Kidney Injury.
    Miano TA; Lautenbach E; Wilson FP; Guo W; Borovskiy Y; Hennessy S
    Clin J Am Soc Nephrol; 2018 Apr; 13(4):542-550. PubMed ID: 29545383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten-year Single Center Experience With Colistin Therapy in NICU.
    Kaya TB; Sürmeli Onay Ö; Aydemir Ö; Tekin AN
    Pediatr Infect Dis J; 2024 Feb; 43(2):165-169. PubMed ID: 37820257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colistin treatment in older adults: why should we know more?
    Öztürk E; Ganidağlı S; Öztürk ZA
    Curr Med Res Opin; 2023 Nov; 39(11):1481-1487. PubMed ID: 37738213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between colistin dose and development of nephrotoxicity.
    Lee YJ; Wi YM; Kwon YJ; Kim SR; Chang SH; Cho S
    Crit Care Med; 2015 Jun; 43(6):1187-93. PubMed ID: 25756417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients.
    Garonzik SM; Li J; Thamlikitkul V; Paterson DL; Shoham S; Jacob J; Silveira FP; Forrest A; Nation RL
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3284-94. PubMed ID: 21555763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary study.
    Dalfino L; Puntillo F; Mosca A; Monno R; Spada ML; Coppolecchia S; Miragliotta G; Bruno F; Brienza N
    Clin Infect Dis; 2012 Jun; 54(12):1720-6. PubMed ID: 22423120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system.
    Pogue JM; Lee J; Marchaim D; Yee V; Zhao JJ; Chopra T; Lephart P; Kaye KS
    Clin Infect Dis; 2011 Nov; 53(9):879-84. PubMed ID: 21900484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher incidence of acute kidney injury with intravenous colistimethate sodium compared with polymyxin B in critically ill patients at a tertiary care medical center.
    Akajagbor DS; Wilson SL; Shere-Wolfe KD; Dakum P; Charurat ME; Gilliam BL
    Clin Infect Dis; 2013 Nov; 57(9):1300-3. PubMed ID: 23840000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic predisposition and high exposure to colistin in the early treatment period as independent risk factors for colistin-induced nephrotoxicity.
    Mathew SK; Chapla A; Venkatesan P; Eriyat V; Aruldhas BW; Prabha R; Neely MN; Rao SV; Kandasamy S; Mathew BS
    Clin Transl Sci; 2024 Mar; 17(3):e13764. PubMed ID: 38476095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abrupt increased serum creatinine in a hyperferritinemia patient treated with deferoxamine after cord blood transplantation: a case report with literature review.
    Nakayama H; Kamoda Y; Tanuma M; Kato T; Usuki K
    J Pharm Health Care Sci; 2023 Jun; 9(1):18. PubMed ID: 37259120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Serum Creatinine Levels with Reference Change Value in Patients Receiving Colistin Treatment.
    Cinpolat HY; Alkan S; Altinisik HB; Cakir DU; Oguzman H
    Lab Med; 2023 Nov; 54(6):582-586. PubMed ID: 36883236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics, Influencing Factors, Predictive Scoring System, and Outcomes of the Patients with Nephrotoxicity Associated with Administration of Intravenous Colistin.
    Sangthawan P; Geater AF; Naorungroj S; Nikomrat P; Nwabor OF; Chusri S
    Antibiotics (Basel); 2021 Dec; 11(1):. PubMed ID: 35052879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colistin Nephrotoxicity-Age and Baseline kidney Functions Hold the Key.
    Prasannan BK; Mukthar FC; Unni VN; Mohan S; Vinodkumar K
    Indian J Nephrol; 2021; 31(5):449-453. PubMed ID: 34880554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low albumin levels are independently associated with neonatal acute kidney injury: a report from AWAKEN Study Group.
    Nada A; Askenazi D; Kupferman JC; Mhanna M; Mahan JD; Boohaker L; Li L; Griffin RL;
    Pediatr Nephrol; 2022 Jul; 37(7):1675-1686. PubMed ID: 34657971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired Bartter-like Syndrome Presenting with Polyuria and Reversible Hypokalemia Associated with Colistin Use in a Critically Ill Pediatric Patient.
    Yavas DP; Ekinci F; Horoz OO; Gundeslioglu OO; Atmis B; Yildizdas D
    Indian J Crit Care Med; 2021 Jul; 25(7):822-824. PubMed ID: 34316180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Colistin Dosing on the Incidence of Nephrotoxicity in a Tertiary Care Hospital in Saudi Arabia.
    Almutairy R; Aljrarri W; Noor A; Elsamadisi P; Shamas N; Qureshi M; Ismail S
    Antibiotics (Basel); 2020 Aug; 9(8):. PubMed ID: 32781593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colistin Resistance in Enterobacterales Strains - A Current View.
    Stefaniuk EM; Tyski S
    Pol J Microbiol; 2019 Dec; 68(4):417-427. PubMed ID: 31880886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment Options for Colistin Resistant
    Petrosillo N; Taglietti F; Granata G
    J Clin Med; 2019 Jun; 8(7):. PubMed ID: 31261755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymyxin Acute Kidney Injury: Dosing and Other Strategies to Reduce Toxicity.
    Nation RL; Rigatto MHP; Falci DR; Zavascki AP
    Antibiotics (Basel); 2019 Mar; 8(1):. PubMed ID: 30875778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.